Found 19 clinical trials
Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia (RISE).
stable, and are eligible for risperidone treatment.
- 73 views
- 22 Dec, 2020
- 1 location
Study Seeking Patients with Schizophrenia
Study Seeking Patients with Schizophrenia
- 440 views
- 25 Mar, 2021
- 1 location
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
To explore the whole-brain anatomical and functional abnormalities in drug-naive patients with schizophrenia ,drug-naive patients with BD, drug-naive patients with MDD and healthy controls by using a combination of cross-sectional and longitudinal study designs, including a longitudinal study with 8 weeks of drugs treatment. And explore whether there are shared …
- 0 views
- 25 Jan, 2021
- 1 location
Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
utilize a stringent randomized, double-blinded, parallel group clinical trial design. B2 group will serve as psychosis control with risperidone as medication control. The study is designed to evaluate
- 0 views
- 12 Mar, 2022
- 1 location
Risperidone for the Treatment of Huntington's Disease Involuntary Movements
The purpose of this study is to assess the safety and benefit of risperidone for the treatment of chorea (involuntary movements) in Huntington's disease. Risperidone is commonly used in clinical
- 105 views
- 24 Jan, 2022
- 1 location
Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
This study aims to compare two FDA approved medications (aripiprazole and risperidone) for the treatment of behavioral dysregulation in children with autism spectrum disorders. This trial, done
- 0 views
- 21 Dec, 2021
- 1 location
Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT
The aim of this study is to test whether therapeutic drug monitoring of risperidone in children with autism spectrum disorder and comorbid behavioral problems is able to reduce metabolic side
- 0 views
- 16 Dec, 2021
- 1 location
Cannabidiol for Treatment of Recent-onset Psychosis With Comorbid Cannabis Use
This trial examines the efficacy of cannabidiol (CBD) versus risperidone for treatment of psychosis and cessation of cannabis use in patients with recent-onset psychosis and comorbid cannabis
- 0 views
- 17 Jun, 2021
- 1 location
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
Plasma half-life has routinely been used to establish the dosing schedule of antipsychotics; for example, it is recommended that agents with a short plasma half-life be administered multiple times per day. However, to date, several randomized controlled trials (RCTs) have shown no differences in clinical outcomes between once- and twice-daily …
- 141 views
- 23 Feb, 2022
- 1 location
CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr (CASCADE)
This is a randomized, placebo-controlled study but all study participants will receive the active study medication at some point during the study for at least 12 weeks, and some children with receive CBD for the entire study.
- 0 views
- 22 Mar, 2022
- 1 location
- 1
- 2